Cite
HARVARD Citation
Syrbe, U. et al. (2014). SAT0371 Ustekinumab Treatment in Ankylosing Spondylits (AS) Patients Does not Modulate Effector CD4+ T Cell Frequencies Including TH17 Cells. Annals of the rheumatic diseases. pp. 727-728. [Online].